Psychiatric ICD-10 Coding Principles
Accurate ICD-10 coding in psychiatry requires specificity that goes beyond the primary diagnosis. Payers use diagnosis codes to determine medical necessity, authorize visit frequency, and approve medications. A generic depression code (F32.9, unspecified) does not support the same level of service authorization as a specific code (F33.1, major depressive disorder, recurrent, moderate). Coding to the highest level of specificity supported by the clinical documentation reduces denials, supports appropriate E/M levels, and facilitates prior authorization approvals for psychiatric medications.
Schizophrenia Spectrum (F20.x)
Schizophrenia codes require specification of the type and current status. Paranoid schizophrenia is coded as F20.0, disorganized (hebephrenic) as F20.1, catatonic as F20.2, undifferentiated as F20.3, and residual as F20.5. Schizoaffective disorder uses F25.0 (bipolar type) or F25.1 (depressive type). Each code requires a fifth digit or additional documentation for the current episode status.
Coding considerations: schizophrenia diagnoses support high-complexity E/M coding (99214 or 99215) because management involves antipsychotic medications with serious side effect profiles (metabolic syndrome, tardive dyskinesia, agranulocytosis with clozapine), regular laboratory monitoring, and complex polypharmacy decisions. Document the specific antipsychotic being managed, monitoring labs ordered, and any side effect assessment to support the MDM complexity.
Bipolar Disorder (F31.x)
Bipolar disorder coding specifies the current episode type and severity. F31.0: bipolar I, current episode hypomanic. F31.1x: bipolar I, current episode manic (F31.10 without psychotic features, F31.11 mild, F31.12 moderate, F31.13 severe without psychotic features, F31.2 with psychotic features). F31.3x: bipolar I, current episode depressed (F31.30 unspecified, F31.31 mild, F31.32 moderate, F31.4 severe without psychotic features, F31.5 with psychotic features). F31.7x: bipolar I, currently in remission (F31.71 partial, F31.72 full, F31.73 unspecified). Bipolar II disorder uses F31.81.
Coding tip: update the bipolar code at each visit to reflect the current episode status. A patient who was F31.32 (depressed, moderate) at the last visit may be F31.73 (in remission) now. Keeping the diagnosis current supports appropriate medication management documentation and prevents inconsistencies that trigger audit flags. Using F31.9 (bipolar disorder, unspecified) when clinical documentation supports a more specific code increases denial risk.
Major Depressive Disorder (F32-F33)
MDD coding distinguishes single episode (F32.x) from recurrent (F33.x). Most adult patients with ongoing depression treatment should be coded as recurrent. F32.0/F33.0: mild. F32.1/F33.1: moderate. F32.2/F33.2: severe without psychotic features. F32.3/F33.3: severe with psychotic features. F33.40/F33.41/F33.42: in remission (unspecified, partial, full). Use validated screening tools (PHQ-9) to support the severity level documented.
Coding impact on billing: severe MDD (F32.2, F33.2) with active treatment supports higher E/M complexity and more frequent visit authorization than mild MDD (F32.0, F33.0). When a patient presents with moderate to severe symptoms, document the PHQ-9 score, functional impairment, and treatment complexity to align the severity code with the E/M level. A patient coded as F33.0 (mild) who is billed at 99215 will likely trigger a medical necessity review.
Anxiety Disorders (F41.x)
Generalized anxiety disorder uses F41.1. Panic disorder uses F41.0 (with or without agoraphobia noted separately as F40.0x). Mixed anxiety and depressive disorder uses F41.8. Social anxiety disorder uses F40.10. Specific phobias use F40.2xx codes. Post-traumatic stress disorder uses F43.1x (F43.10 unspecified, F43.11 acute, F43.12 chronic). Obsessive-compulsive disorder uses F42.x (F42.2 mixed, F42.3 hoarding, F42.4 excoriation, F42.8 other, F42.9 unspecified).
Common coding error: using F41.9 (anxiety disorder, unspecified) when the clinical documentation clearly describes generalized anxiety disorder (F41.1) or panic disorder (F41.0). Unspecified codes increase the probability of medical necessity denials, particularly for medication prior authorizations. When requesting PA for an SSRI or SNRI for anxiety, a specific diagnosis code supports the clinical rationale better than an unspecified code.
ADHD (F90.x)
ADHD coding requires specification of the presentation type. F90.0: predominantly inattentive type. F90.1: predominantly hyperactive-impulsive type. F90.2: combined type. F90.8: other specified attention-deficit hyperactivity disorder. F90.9: unspecified. For adult ADHD, the same codes apply. There is no age-specific distinction in the ICD-10 coding, but documentation should note that the condition was present before age 12 per DSM-5 criteria.
ADHD coding has direct implications for stimulant medication authorization. Many payers require confirmation of the specific ADHD type and documentation of symptom severity before approving brand-name stimulants. Use F90.0, F90.1, or F90.2 rather than F90.9. Include standardized rating scale results (Conners, ASRS for adults) in the documentation to support both the diagnosis code specificity and the medication PA request.
Coding for Comorbid Conditions
Psychiatric patients frequently have multiple diagnoses. List all active conditions being managed in the encounter. A patient with bipolar I disorder (F31.32), generalized anxiety (F41.1), and ADHD (F90.2) has three diagnoses that contribute to the complexity of medication management. Documenting and coding all active conditions supports higher E/M levels because managing multiple psychiatric medications for comorbid conditions meets the criteria for moderate to high complexity medical decision-making.